09:03:28 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-30 Kvartalsrapport 2024-Q3
2024-07-18 Kvartalsrapport 2024-Q2
2024-04-25 Kvartalsrapport 2024-Q1
2024-03-20 Ordinarie utdelning OKDBV 0.07 EUR
2024-03-20 Ordinarie utdelning OKDAV 0.07 EUR
2024-03-19 Årsstämma 2024
2024-02-16 Bokslutskommuniké 2023
2023-10-31 Kvartalsrapport 2023-Q3
2023-07-21 Kvartalsrapport 2023-Q2
2023-04-27 Kvartalsrapport 2023-Q1
2023-03-22 Ordinarie utdelning OKDBV 0.06 EUR
2023-03-22 Ordinarie utdelning OKDAV 0.06 EUR
2023-03-21 Årsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-10-27 Kvartalsrapport 2022-Q3
2022-07-22 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-03-16 Ordinarie utdelning OKDAV 0.04 EUR
2022-03-16 Ordinarie utdelning OKDBV 0.04 EUR
2022-03-15 Årsstämma 2022
2022-02-18 Bokslutskommuniké 2021
2021-10-27 Kvartalsrapport 2021-Q3
2021-07-20 Kvartalsrapport 2021-Q2
2021-04-27 Kvartalsrapport 2021-Q1
2021-03-17 Ordinarie utdelning OKDAV 0.03 EUR
2021-03-17 Ordinarie utdelning OKDBV 0.03 EUR
2021-03-16 Årsstämma 2021
2021-02-18 Bokslutskommuniké 2020
2020-10-23 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-04-24 Kvartalsrapport 2020-Q1
2020-03-18 Ordinarie utdelning OKDBV 0.09 EUR
2020-03-18 Ordinarie utdelning OKDAV 0.09 EUR
2020-03-17 Årsstämma 2020
2020-02-07 Bokslutskommuniké 2019
2019-07-17 Kvartalsrapport 2019-Q2
2019-03-20 Ordinarie utdelning OKDBV 0.09 EUR
2019-03-20 Ordinarie utdelning OKDAV 0.09 EUR
2019-03-19 Årsstämma 2019
2018-11-01 Kvartalsrapport 2018-Q3
2018-07-18 Kvartalsrapport 2018-Q2
2018-04-27 Kvartalsrapport 2018-Q1
2018-03-20 Ordinarie utdelning OKDAV 0.09 EUR
2018-03-20 Ordinarie utdelning OKDBV 0.09 EUR
2018-03-19 Årsstämma 2018
2018-02-13 Bokslutskommuniké 2017
2017-10-25 Kvartalsrapport 2017-Q3
2017-07-21 Kvartalsrapport 2017-Q2
2017-04-28 Kvartalsrapport 2017-Q1
2017-03-15 Ordinarie utdelning OKDBV 0.14 EUR
2017-03-15 Ordinarie utdelning OKDAV 0.14 EUR
2017-03-14 Årsstämma 2017
2017-02-13 Bokslutskommuniké 2016
2016-10-20 Kvartalsrapport 2016-Q3
2016-07-19 Kvartalsrapport 2016-Q2
2016-04-22 Kvartalsrapport 2016-Q1
2016-03-15 Ordinarie utdelning OKDAV 0.13 EUR
2016-03-15 Ordinarie utdelning OKDBV 0.13 EUR
2016-03-14 Årsstämma 2016
2016-02-05 Bokslutskommuniké 2015
2015-10-22 Kvartalsrapport 2015-Q3
2015-09-09 Kapitalmarknadsdag 2015
2015-07-17 Kvartalsrapport 2015-Q2
2015-04-23 Kvartalsrapport 2015-Q1
2015-03-31 Ordinarie utdelning OKDBV 0.00 EUR
2015-03-31 Ordinarie utdelning OKDAV 0.00 EUR
2015-03-30 Årsstämma 2015
2015-02-06 Bokslutskommuniké 2014
2014-10-23 Kvartalsrapport 2014-Q3
2014-07-24 Kvartalsrapport 2014-Q2
2014-04-24 Kvartalsrapport 2014-Q1
2014-03-25 Ordinarie utdelning OKDAV 0.00 EUR
2014-03-25 Ordinarie utdelning OKDBV 0.00 EUR
2014-03-24 Årsstämma 2014
2014-02-07 Bokslutskommuniké 2013
2013-10-24 Kvartalsrapport 2013-Q3
2013-07-25 Kvartalsrapport 2013-Q2
2013-04-25 Kvartalsrapport 2013-Q1
2013-03-21 Ordinarie utdelning OKDAV 0.09 EUR
2013-03-21 Ordinarie utdelning OKDBV 0.09 EUR
2013-03-20 Årsstämma 2013
2013-02-07 Bokslutskommuniké 2012
2012-10-25 Kvartalsrapport 2012-Q3
2012-07-26 Kvartalsrapport 2012-Q2
2012-04-26 Kvartalsrapport 2012-Q1
2012-03-27 Ordinarie utdelning OKDBV 0.08 EUR
2012-03-27 Ordinarie utdelning OKDAV 0.08 EUR
2012-03-26 Årsstämma 2012
2012-02-09 Bokslutskommuniké 2011
2011-10-27 Kvartalsrapport 2011-Q3
2011-08-04 Kvartalsrapport 2011-Q2
2011-04-28 Kvartalsrapport 2011-Q1
2011-04-07 Ordinarie utdelning OKDBV 0.05 EUR
2011-04-07 Bonusutdelning OKDAV 0.13
2011-04-07 Bonusutdelning OKDBV 0.13
2011-04-07 Ordinarie utdelning OKDAV 0.05 EUR
2011-03-07 Bokslutskommuniké 2010
2010-04-08 Ordinarie utdelning OKDBV 0.12 EUR
2010-04-08 Ordinarie utdelning OKDAV 0.12 EUR
2010-04-07 Årsstämma 2010
2010-02-11 Bokslutskommuniké 2009
2009-04-17 Ordinarie utdelning OKDBV 0.08 EUR
2009-04-17 Ordinarie utdelning OKDAV 0.08 EUR
2008-03-18 Ordinarie utdelning OKDBV 0.08 EUR
2008-03-18 Ordinarie utdelning OKDAV 0.08 EUR
2007-03-14 Ordinarie utdelning OKDBV 0.06 EUR
2007-03-14 Ordinarie utdelning OKDAV 0.06 EUR

Beskrivning

LandFinland
ListaMid Cap Helsinki
SektorHälsovård
IndustriLäkemedel & Handel
Oriola är en läkemedelskoncern med särskilt fokus inom distribution av läkemedel till andra aktörer inom branschen. Bolaget erbjuder tjänster till apotek och övriga läkemedelsbolag, vilket exempelvis innefattar förhandlingar med leverantörer och distribution av produkter. Idag innehas störst verksamhet inom Norden och Baltikum. Huvudkontoret ligger i Esbo.
2021-10-04 09:00:00

Oriola Corporation Insider information 4 October 2021 at 10.00 am.

Oriola plans to restructure its operating model and initiates cooperation negotiations

Oriola Corporation is streamlining processes to improve operational efficiency and reduce cost for increased profitability. The objective is to optimise the operating model and organisational structure for better accountability and transparency as well as reduced organisational complexity.

New country-based operating model

Oriola targets to implement a country-based organisation where the current business areas Pharma and Retail and Operations function are transformed into geographical business areas, Finland and Sweden. The Swedish pharmacy operations directly serving consumers in Sweden would continue as its own business area, the same way as it is today. Oriola plans to implement the new operating model and the structure from the beginning of 2022.

Restructuring enables efficient operations

Oriola will initiate statutory employee cooperation negotiations to reorganise and streamline the organisation as well as to improve the profitability. The negotiations concern approximately 600 employees in Finland and Sweden. Production employees in distribution and dose-dispensing businesses, staffing services employees in Finland and pharmacy employees in Sweden are excluded from the negotiations. According to the company's preliminary estimate, the negotiations could lead to a maximum reduction of 130 positions. This would be equivalent to an annual cost saving of at least 7 million euros.

"During the most recent years, Oriola's financial performance has been unsatisfactory. By simplifying our operating model and organisational structure we can enable Oriola's profitable transformation. With the local business approach, we can fulfil customers' needs better and strengthen our ability to respond faster to the changes in market environment. The planned measures will not affect the security of pharmaceutical supply in Finland and Sweden," says Oriola's CEO Elisa Markula.

Now announced turnaround measures to improve the profitability and cost-competitiveness represent the first phase in Oriola's transformation. Oriola will continue to seek further measures to improve its profitability.

Oriola Corporation

Elisa Markula
CEO

Further information:

Elisa Markula
CEO
Tel. +358 10 429 2109
Email: elisa.markula@oriola.com

Elina Niemelä
VP, People and Transformation
Tel. +358 40 587 0879
Email: elina.niemela@oriola.com

Distribution:
Nasdaq Helsinki Ltd.
Key media

Released by:
Oriola Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
www.oriola.com